PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to PFIZER REPORTS STRONG THIRD-QUARTER 2022 RESULTS AND RAISES 2022 OUTLOOK

Biohaven Pharma (BHVN) CEO Buys Another $400K in Stock

November 1, 2022 8:19 AM EDT

Biohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.

The value of the purchase was $411,995.

Yesterday, Coric disclosed the purchase of $2.1 million in stock.

... More

Pfizer (PFE) Tops Q3 EPS by 34, Beats on Revenue; Offers FY Guidance

November 1, 2022 6:47 AM EDT

Pfizer (NYSE: PFE) reported Q3 EPS of $1.78, $0.34 better than the analyst estimate of $1.44. Revenue for the quarter came in at $22.6 billion versus the consensus estimate of $21.33 billion.

GUIDANCE:

Pfizer sees FY2022 EPS of $6.30-$6.45, versus the consensus of $6.38. Pfizer sees... More